Insulin
Reviewed
Short answer
Insulin is a family of diabetes medicines. Different products can have different timing, risks, and instructions. Several FDA-approved insulin products exist, including highly similar versions called biosimilars.
The Peptide Field explains research. Its pages are not independently medically reviewed, and they do not diagnose, prescribe, or recommend treatment.
Read the study findingsRelated insulin terms human insulin · insulin analog · rapid-acting insulin · basal insulin
Part of Metabolic peptide medicines
Legal status Is Insulin legal? See the status table
Study and product details
What it is
“Insulin” does not name one single product. It is a hormone made by the pancreas. It is also the name for a family of diabetes medicines. Products may be rapid-acting, short-acting, intermediate-acting, long-acting, or mixed. These products have different timing, risks, and instructions.
Type of peptide: Peptide hormone · family of protein medicines. This describes what the substance is or how it works. It does not show that it is safe, effective, or approved.
What has been studied?
- Strong: Several reliable sources describe this clearly.
Long-term studies that assigned people to groups by chance support closely monitored insulin treatment for specific groups with diabetes.
Studies describe when each product starts working, reaches its strongest effect, and wears off.
Product labels and many years of use describe the main risks, especially dangerously low blood sugar.
High when the product is a real approved product. The exact product and its ingredients still matter.
Products with the same ingredient can differ.
The ingredient name does not tell you everything about a product. Check its other ingredients, its form, how it enters the body, and the use and people covered by the research or approval.
Humalog
May 2025- Ingredients and form
- Several strengths and delivery forms listed in the label
- How it enters the body
- Injection under the skin. Humalog U-100 can also be used in some insulin pumps. Its label allows medical staff to give the U-100 form through a vein after dilution and with close monitoring. The U-200 form must not be used through a vein.
- Use and people covered
- Diabetes treatment for the people and uses listed in the current Humalog label. This example does not describe every insulin product.
- Multiple human insulin and insulin analog products
- Diabetes treatment for the people listed in each product's label
What studies found
The Diabetes Control and Complications Trial (DCCT) put 1,441 people with type 1 diabetes into groups by chance. It compared an intensive insulin plan with a less intensive plan. It followed them for about 6.5 years. The intensive plan lowered the risk of new or worsening eye, kidney, and nerve problems. It also led to two to three times as many severe low-blood-sugar events. Insulin is essential for type 1 diabetes. Insulin treats other forms of diabetes too.
One insulin plan is not right for everyone. Products, schedules, targets, and treatment levels vary by person and product. Evidence for one product, group, or plan does not support switching products on your own. It also does not show that every product can be exchanged freely or used for non-medical reasons.
Which products do these findings apply to?
The name insulin covers many FDA-approved products. They can differ in the amount of medicine, how long they work, how they enter the body, and what their labels allow.
Fact checks
3 statements checked. Read what the results mean.
“Insulin is an established treatment for diabetes.”
Several insulin products have FDA approval. Long-term studies in people support closely monitored insulin plans for specific groups with diabetes. The exact product and care setting still matter.
- What this answer is based on
- Health results from a study with randomly assigned groups
- Limits of this answer
- FDA-approved insulin products and closely monitored treatment plans for specific groups with diabetes.
Sources for this fact check (2)
“All insulin products work the same way and can be swapped freely.”
Insulin products can differ in how fast they work and how much medicine they contain. They can also differ in how they enter the body and what their FDA labels allow. Some biosimilars can be substituted under state law. This does not make every insulin product freely exchangeable.
- What this answer is based on
- Official record or product label
- Limits of this answer
- The exact insulin products, amounts of medicine, ways to give them, and labels reviewed.
Sources for this fact check (2)
“More intensive insulin treatment is always better.”
The DCCT found fewer long-term complications with an intensive plan. It also found about two to three times as many severe low-blood-sugar events. The right treatment level differs by person and needs medical monitoring.
- What this answer is based on
- Health results from a study with randomly assigned groups
- Limits of this answer
- The specific intensive plan and people with type 1 diabetes studied in the DCCT.
Sources for this fact check (2)
Risks and safety limits
Hypoglycemia means dangerously low blood sugar. It can be severe and life-threatening. Product mix-ups and changes without medical guidance can cause serious harm. This guide does not give dose calculations, correction factors, injection steps, or advice for changing an insulin plan.
The 2026 WADA list prohibits insulin at all times for athletes it covers, unless an applicable therapeutic-use exemption allows it.
Reviewed .Check the rules for athletes ↗Read the official rules ↗Terms used in the studies
- analog
- a changed version made to act like another substance
- randomized
- assigned to study groups by chance
- outcome
- what the study measured
- peptide
- a short chain of amino acids
- amino acid
- a small building block that makes peptides and proteins
Read the sources
Show 8 sources
Review history
Checked the current Humalog label, the main DCCT results, and the 2026 WADA rule for insulin. Kept the product and study limits.
Expanded product, safety, and claim source details.
Not independently medically reviewed. This page is not a dosing, sourcing, or treatment guide.
Report a factual error